Searchable abstracts of presentations at key conferences in endocrinology

ea0032p512 | Endocrine tumours and neoplasia | ECE2013

Biochemical diagnosis of pheochromocytoma using plasma free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions

Darr Roland , Peitzsch Mirko , Pamporaki Christina , Prejbisz Aleksander , Fassnacht Martin , Beuschlein Felix , Neumann Hartmut , Januszewicz Andrzej , Lenders Jacques , Eisenhofer Graeme

Objective: To document influences of sampling of blood under supine fasting versus seated non-fasting conditions on diagnosis of pheochromocytoma using plasma concentrations of normetanephrine, metanephrine and methoxytyramine (P-NMN/MN/MTY).Design and methods: P-NMN/MN/MTY were measured by liquid chromatography with tandem mass spectrometry in 695 patients at five centers, two of which complied with requirements for supine sampling after an overnight fa...

ea0022oc4.2 | Adrenals | ECE2010

ESE Young Investigator Award

Spyroglou Ariadni , Wagner Sibylle , Bidlingmaier Martin , Bozoglu Tarik , Rathkolb Birgit , Schrewe Anja , de Angelis Martin Hrabe , Beuschlein Felix

In an attempt to define novel genetic loci involved in the pathophysiology of primary aldosteronism a mutagenesis screen after treatment with the alkylating agent N-ethyl-N-nitrosourea was established for the parameter aldosterone. One of the established mouse lines with hyperaldosteronism was phenotypically and genetically characterized. Affected animals showed an increased aldosterone to renin ratio (males unaffected, 1.1±0.1 pg/ml per ng per ml per hour v...

ea0020htb1 | Hot topics: Basic | ECE2009

Hot topics: Basic

Spyroglou Ariadni , Wagner Sibylle , Manolopoulou Jenny , Hantel Constanze , Reincke Martin , Bidlingmaier Martin , Hrabe de Angelis Martin , Beuschlein Felix

Although primary aldosteronism (PA) is considered to be the most prevalent cause of secondary hypertension the underlying genetic mechanisms have been elucidated only for the rare familial forms of the disease. In an attempt to define novel genetic loci involved in the pathophysiology of PA a phenotype-driven mutagenesis screening after treatment with the alkylating agent N-ethyl-N-nitrosourea was established for the parameter aldosterone. The aldosterone values ...

ea0020oc1.2 | Endocrine Tumours | ECE2009

Long-term outcome of laparoscopic versus open adrenalectomy for adrenocortical carcinoma

Fassnacht Martin , Brix David , Fenske Wiebke , Langer Peter , Nies Christoph , Agha Ayman , Beuschlein Felix , Johanssen Sarah , Riedmiller Hubertus , Allolio Bruno

Introduction: Surgery is the established first line treatment in adrenocortical carcinoma (ACC). For benign adrenal tumours, laparoscopic adrenalectomy (LA) has become the treatment of choice. However, the role of LA in ACC remains highly controversial. Data from the German ACC Registry were used to evaluate the technical feasibility of LA in ACC and to compare the long-term outcome after LA with the results of open adrenalectomy (OA).Methods: Out of 521...

ea0020oc2.4 | Diabetes & Obesity | ECE2009

Mc2 receptor in adipocytes is significant for lipid composition and regular lipolysis

Hatiboglu Nilay , Betz Matthias J , Hadaschick Dirk , Mauracher Brigitte , Rachl Monika , Demmelmair Johann , Koletzko Berthold , Slawik Marc , Beuschlein Felix

The melanocortin system is significant for energy homeostasis and receptors have distinct tissue specific expression. The melanocortin 2-receptor (Mc2r) transmits ACTH dependent signalling in the adrenal cortex. Increased expression in adipocytes during differentiation indicates relevance for lipid homeostasis. Mc2r activation in adipocytes results in increased lipolysis, however, implication compared to norepinephrine (NE) stimulated lipolysis is unknown. To further define fu...

ea0020p181 | Endocrine tumours and neoplasia | ECE2009

Steroidogenic factor 1 – a valuable diagnostic and prognostic tool in patients with adrenocortical carcinoma

Sbiera Silviu , Schmull Sebastian , Voelker Hans-Ullrich , Kraus Luitgard , Beuschlein Felix , Willenberg Holger , Hahner Stefanie , Allolio Bruno , Fassnacht Martin

Objectives: No immunohistochemical marker has yet been established to reliably differentiate adrenocortical tumors from other adrenal masses (e.g. metastases). Thus, a panel of several markers like melan A and inhibin is currently used for this purpose, but suffers from limited diagnostic accuracy. We hypothesized that expression of steroidogenic factor 1 (SF-1), a nuclear transcription factor involved in adrenal development and steroidogenesis, might hold significant diagnost...

ea0016p28 | Adrenal | ECE2008

Establishment of a mutagenesis screen to identify mice with high aldosterone levels

Spyroglou Ariadni , Wagner Sibylle , Manolopoulou Jenny , Hantel Constanze , Reincke Martin , Bidlingmaier Martin , de Angelis Martin Hrabe , Beuschlein Felix

According to recent studies, primary aldosteronism is considered to be responsible for almost 10% of all cases of arterial hypertension. The genetic background of this common disease, however, has been elucidated only for the rare familial types whereas in the large majority of sporadic cases it still remains unclear. In an attempt to define novel genetic mechanisms of hyperaldosteronism we utilized a random mutagenesis screen after treatment with the alkylating agent N...

ea0014oc3.5 | Endocrine tumors & neoplasia | ECE2007

[123I]Iodometomidate as a radiotracer for adrenal scintigraphy – first clinical experience

Hahner Stefanie , Stuermer Andrea , Fassnacht Martin , Kreissl Michael , Reiners Christoph , Beuschlein Felix , Zink Martina , Zolle Ilse , Schirbel Andreas , Allolio Bruno

Adrenal masses are highly prevalent tumours comprising of a variety of entities. Therefore, therapeutic consequences also vary considerably. The CYP11B-specific PET-tracer [11C]metomidate has been shown to be suitable to characterize adrenal lesions. However, its availability is restricted to PET-centers with an on-site cyclotron. Also imaging is hindered by the short tracer half-life (20 min). Therefore, we have developed [123I]iodometomidate as a tracer...

ea0075a17 | Adrenal gland | EYES2021

Characterization of transcriptional and miRNA based dysregulations in Cushing’s syndrome

Vetrivel Sharmilee , Zhang Ru , Osswald Andrea , Engel Mareen , Beuschlein Felix , Chen Alon , Sbiera Silviu , Reincke Martin , Riester Anna

Introduction: Transcriptional regulation of gene expression by miRNAs is critical for the fine-tuning of adrenal stress response. However, its role in hypercortisolism has not been explored well. The study addresses this gap using adrenal samples of 3 patient groups from the German Cushing’s registry: Cortisol-Producing-Adenoma (CPA), Primary Bilateral Adrenal Hyperplasia (PBMAH) and controls (adrenal samples of patients with pheochromocytoma).Metho...

ea0099ep600 | Pituitary and Neuroendocrinology | ECE2024

Hypogonadism in male patients with cushing’s syndrome: prevalence and outcome

Nowak Elisabeth , Vogel Frederick , Braun Leah , Zopp Stephanie , Rubinstein German , Adam Pia , Schweizer Junia , Ritzel Katrin , Beuschlein Felix , Reincke Martin

Background: Secondary hypogonadism (SH) is a common comorbidity of Cushing’s syndrome (CS) in men. There is a large overlap in associated symptoms and comorbidities between hypogonadism and hypercortisolism. To date, the influence of coexistent SH on clinical and biochemical parameters in CS is largely unknown and longitudinal data investigating its recovery during the remission phase are scarce.Hypothesis: We hypothesized that SH is a frequent and ...